Organon & (OGN) Profit Metrics

Price: $13.16
Market Cap: $3.39B
Avg Volume: 3.94M
Country: US
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.686
52W Range: $10.45-23.1
Website: Organon &
Profit Metrics Summary (Annual)

According to Organon &'s latest annual financial reports:

  • The company has reported a gross profit of 3.71B, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 58.02%, with a year-over-year growth of -0.88%.
  • Organon &'s EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.60B. The EBITDA margin stands at 25.05%, showing a growth of 11.70% compared to the previous year.
  • The operating income, representing the profit from business operations before taxes and interest, stands at 1.49B. The operating margin is 23.21%, with a year-over-year growth of 11.98%.
  • The net income, which shows the company's total earnings or profit after all expenses, is 864.00M. The net profit margin is 13.49%, demonstrating a growth of -15.54% from the previous year.

These metrics provide a comprehensive overview of Organon &'s profitability and operational efficiency over the past year.

Gross Profit

$3.71B

Gross Profit Margin (2023)

58.02%

EBITDA

$1.60B

EBITDA Margin

25.05%

Operating Income (2023)

$1.49B

Operating Margin

23.21%

Net Income

$864.00M

Net Profit Margin

13.49%

Historical Gross Profit
$6.60B$6.60B$6.00B$6.00B$5.40B$5.40B$4.80B$4.80B$4.20B$4.20B$3.60B$3.60BGross Profit20182018201920192020202020212021202220222023202320242024
Historical Gross Profit Margin
70.76%70.76%56.61%56.61%42.46%42.46%28.30%28.30%14.15%14.15%0.00%0.00%Gross Profit Margin2018201820192019202020202021202120222022202320232024202420252025
Historical Gross Profit Growth
8.24%8.24%3.11%3.11%-2.02%-2.02%-7.15%-7.15%-12.28%-12.28%-17.41%-17.41%Gross Profit Growth2018201820192019202020202021202120222022202320232024202420252025
Historical EBITDA
$6.00B$6.00B$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00BEBITDA20182018201920192020202020212021202220222023202320242024
Historical EBITDA Margin
53.75%53.75%43.00%43.00%32.25%32.25%21.50%21.50%10.75%10.75%0.00%0.00%EBITDA Margin2018201820192019202020202021202120222022202320232024202420252025
Historical EBITDA Growth
11.70%11.70%1.50%1.50%-8.70%-8.70%-18.91%-18.91%-29.11%-29.11%-39.31%-39.31%EBITDA Growth2018201820192019202020202021202120222022202320232024202420252025
Historical Operating Income
$4.20B$4.20B$3.50B$3.50B$2.80B$2.80B$2.10B$2.10B$1.40B$1.40B$700.00M$700.00MOperating Income20182018201920192020202020212021202220222023202320242024
Historical Operating Profit Margin
49.47%49.47%39.57%39.57%29.68%29.68%19.79%19.79%9.89%9.89%0.00%0.00%Operating Profit Margin2018201820192019202020202021202120222022202320232024202420252025
Historical Operating Income Growth
42.17%42.17%25.10%25.10%8.03%8.03%-9.04%-9.04%-26.11%-26.11%-43.17%-43.17%Operating Income Growth2018201820192019202020202021202120222022202320232024202420252025
Historical Net Income
$3.60B$3.60B$3.00B$3.00B$2.40B$2.40B$1.80B$1.80B$1.20B$1.20B$600.00M$600.00MNet Income20182018201920192020202020212021202220222023202320242024
Historical Net Profit Margin
41.38%41.38%33.10%33.10%24.83%24.83%16.55%16.55%8.28%8.28%0.00%0.00%Net Profit Margin2018201820192019202020202021202120222022202320232024202420252025
Historical Net Income Growth
66.85%66.85%49.47%49.47%32.08%32.08%14.70%14.70%-2.69%-2.69%-20.07%-20.07%-37.45%-37.45%Net Income Growth2018201820192019202020202021202120222022202320232024202420252025
Organon & Historical Profit Metrics
Gross Profit
EBITDA
Operating Income
Net Income
$7.00B$7.00B$6.00B$6.00B$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00Profit Metrics20182018201920192020202020212021202220222023202320242024
Organon & Historical Profits

The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.

Year Gross Profit Gross Profit Growth Operating Income Operating Income Growth Net Income Net Income Growth EBITDA EBITDA Growth
2024 $3.71B -0.88% $1.49B 11.98% $864.00M -15.54% $1.60B 11.70%
2023 $3.75B -3.40% $1.33B -10.22% $1.02B 11.56% $1.44B -15.03%
2022 $3.88B -1.07% $1.48B -8.71% $917.00M -32.12% $1.69B -6.84%
2021 $3.92B -17.41% $1.62B -43.17% $1.35B -37.45% $1.81B -39.31%
2020 $4.75B -13.70% $2.85B -25.94% $2.16B -32.88% $2.99B -28.49%
2019 $5.50B 8.24% $3.85B 42.17% $3.22B 49.47% $4.18B -4.54%
2018 $5.08B -14.01% $2.71B -17.30% $2.15B 19.54% $4.38B -13.78%
2017 $5.91B 0.00% $3.27B 0.00% $1.80B 0.00% $5.08B 0.00%

Related Metrics

Explore detailed financial metrics and analysis for OGN.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio